Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Nyberg

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Immunoprotection of xenocytes in a hollow fiber bioartificial liverS L Nyberg, J L Platt, K Shirabe, et al.
Digestive Diseases (Basel, Switzerland)|November 1, 1995
Review of support systems used in the management of fulminant hepatic failureB M McGuire, T D Sielaff, S L Nyberg, et al.
Biotechnology and Bioengineering|January 20, 1993
Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liverS L Nyberg, R A Shatford, M V Peshwa, et al.
Annals of Surgery|July 1, 1994
Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liverS L Nyberg, R P Remmel, H J Mann, et al.
Clinical Transplantation|November 15, 1997
Grandparent donors in a living related renal transplant programS L Nyberg, J C Manivel, M E Cook, et al.
Transplantation Proceedings|July 15, 2014
Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case reportH A Personett, S L Larson, E N Frazee, et al.
Surgery|April 25, 2000
Cytoprotective influence of ZVAD-fmk and glycine on gel-entrapped rat hepatocytes in a bioartificial liverS L Nyberg, J A Hardin, L E Matos, et al.
Transplantation Proceedings|April 1, 1993
Demonstration of biochemical function by extracorporeal xenohepatocytes in an anhepatic animal modelS L Nyberg, W D Payne, B Amiot, et al.
Scientific Reports|April 30, 2021
The Voronoi theory of the normal liver lobular architecture and its applicability in hepatic zonationC Lau, B Kalantari, K P Batts, et al.
Anesthesiology|August 17, 2001
Fatal hepatitis associated with isoflurane exposure and CYP2A6 autoantibodiesJ L Martin, M T Keegan, G M Vasdev, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Immunoprotection of xenocytes in a hollow fiber bioartificial liverS L Nyberg, J L Platt, K Shirabe, et al.
Digestive Diseases (Basel, Switzerland)|November 1, 1995
Review of support systems used in the management of fulminant hepatic failureB M McGuire, T D Sielaff, S L Nyberg, et al.
Biotechnology and Bioengineering|January 20, 1993
Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liverS L Nyberg, R A Shatford, M V Peshwa, et al.
Annals of Surgery|July 1, 1994
Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liverS L Nyberg, R P Remmel, H J Mann, et al.
Clinical Transplantation|November 15, 1997
Grandparent donors in a living related renal transplant programS L Nyberg, J C Manivel, M E Cook, et al.
Transplantation Proceedings|July 15, 2014
Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case reportH A Personett, S L Larson, E N Frazee, et al.
Surgery|April 25, 2000
Cytoprotective influence of ZVAD-fmk and glycine on gel-entrapped rat hepatocytes in a bioartificial liverS L Nyberg, J A Hardin, L E Matos, et al.
Transplantation Proceedings|April 1, 1993
Demonstration of biochemical function by extracorporeal xenohepatocytes in an anhepatic animal modelS L Nyberg, W D Payne, B Amiot, et al.
Scientific Reports|April 30, 2021
The Voronoi theory of the normal liver lobular architecture and its applicability in hepatic zonationC Lau, B Kalantari, K P Batts, et al.
Anesthesiology|August 17, 2001
Fatal hepatitis associated with isoflurane exposure and CYP2A6 autoantibodiesJ L Martin, M T Keegan, G M Vasdev, et al.
Pageof 5